APA (7th ed.) Citation

A, K., KJ, J., KA, G., JF, B., N, B., C, B., . . . Canada, O. B. O. P. A. B. C. (2026). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update). Current oncology (Toronto, Ont.), 33(4), . https://doi.org/10.3390/curroncol33040200

Chicago Style (17th ed.) Citation

A, Kumar, et al. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)." Current Oncology (Toronto, Ont.) 33, no. 4 (2026). https://doi.org/10.3390/curroncol33040200.

MLA (9th ed.) Citation

A, Kumar, et al. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)." Current Oncology (Toronto, Ont.), vol. 33, no. 4, 2026, https://doi.org/10.3390/curroncol33040200.